المؤلفون: Yu. A. Vakhrushev, S. Ye. Andreeva, A. Ya Gudkova, T. S. Kovalchuk, D. Yu. Alekseeva, A. A. Khodot, E. S. Vasichkina, O. O. Yaznevich, M. A. Bortcova, A. A. Kostareva, Ю. А. Вахрушев, С. Е. Андреева, Г. А. Яковлевна, Т. С. Ковальчук, Д. Ю. Алексеева, А. А. Ходот, Е. С. Васичкина, О. О. Язневич, М. А. Борцова, А. А. Костарева

المساهمون: The work was supported by a grant from RSF No. 20-15-00271П "The role of cytoskeletal and Z-disc associated proteins in the pathogenesis of myocardial and skeletal muscle diseases"., Работа выполнена при поддержке гранта РНФ № 20-15-00271П «Роль цитоскелетных и Z-диск ассоциированных белков в патогенезе заболеваний миокарда и скелетной мускулатуры».

المصدر: Translational Medicine; Том 10, № 5 (2023); 430-448 ; Трансляционная медицина; Том 10, № 5 (2023); 430-448 ; 2410-5155 ; 2311-4495

مصطلحات موضوعية: укорачивающие генетические варианты, hypertrophic cardiomyopathy, noncompaction cardiomyopathy, restrictive cardiomyopathy, titin, дилатационная кардиомиопатия, некомпактный миокард, рестриктивная кардиомиопатия, тайтин

وصف الملف: application/pdf

Relation: https://transmed.almazovcentre.ru/jour/article/view/900/538; Linke WA. Sense and stretchability: The role of titin and titin-associated proteins in myocardial stresssensing and mechanical dysfunction †.; Linke WA, Hamdani N. Gigantic business: Titin properties and function through thick and thin. Circ Res. 2014;114(6):1052–68.; Opitz CA, Leake MC, Makarenko I, et al. Developmentally Regulated Switching of Titin Size Alters Myofibrillar Stiffness in the Perinatal Heart. Circ Res. 2004 Apr 16;94(7):967–75.; Bang ML, Centner T, Fornoff F, et al. The complete gene sequence of titin, expression of an unusual ≈700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res. 2001 Nov 23;89(11):1065–72.; Вихлянцев И.М., Подлубная З.А. Изофоpмный cоcтав тайтина в мышцаx пpи патологичеcкиx пpоцеccаx. Биофизика. 2008;53(6):1058–072.; Guo W, Schafer S, Greaser ML, et al. RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing. Nat Med. 2012 May;18(5):766–73.; Grützner A, Garcia-Manyes S, Kötter S, et al. Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence. Biophys J. 2009;97(3):825–34.; Tabish AM, Azzimato V, Alexiadis A, et al. Genetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy. Biophys Rev. 2017 Jun 1;9(3):207–23.; Xu YC, Guo YL. Less Is More, Natural Lossof-Function Mutation Is a Strategy for Adaptation. Plant Commun. 2020 Nov 9;1(6):100103.; Вахрушев Ю.А., Вершинина Т.Л., Федотов П.А. и др. Некомпактный миокард левого жеудочка, ассоциированный с укорачивающими вариантами в гене тайтина (TTN). Российский кардиологический журнал. 2020;25(10):4027.; Carmignac V, Salih MAM, Quijano-Roy S, et al. C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy. Ann Neurol. 2007;61(4):340–351.; Ceyhan-Birsoy O, Agrawal PB, Hidalgo C, et al. Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology. 2013 Oct 1;81(14):1205–14.; Haggerty CM, Damrauer SM, Levin MG, et al. Genomics-First Evaluation of Heart Disease Associated With Titin-Truncating Variants. Circulation. 2019 Jul 2;140(1):42–54.; Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: A position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12(8):767–778.; Chauveau C, Rowell J, Ferreiro A. A rising titan: TTN review and mutation update. Hum Mutat. 2014;35(9):1046–59.; Hinson JT, Chopra A, Nafissi N, Polacheck WJ, et al. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science. 2015 Aug 28;349(6251):982–6.; Roberts AM, Ware JS, Herman DS, et al. Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med. 2015 Jan 14;7(270).; Gramlich M, Michely B, Krohne C, et al. Stressinduced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease. J Mol Cell Cardiol. 2009 Sep;47(3):352–8.; Lunde IG, Wakimoto H, Burke MA, et al. Titin A–band truncation in mice causes stress–induced dilated cardiomyopathy. Eur J Heart Fail. 2015;7(1):31.; Van Spaendonck-Zwarts KY, Posafalvi A, Van Den Berg MP, et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur Heart J. 2014 Aug 21;35(32):2165–73.; Ware JS, Amor-Salamanca A, Tayal U, et al. Genetic Etiology for Alcohol-Induced Cardiac Toxicity. J Am Coll Cardiol. 2018;71(20):2293–2302.; Garcia-Pavia P, Kim Y, Restrepo-Cordoba MA, et al. Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy. Circulation. 2019 Jul 2;140(1):31–41.; Herman DS, Lam L, Taylor MRG, et al. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012 Feb 16;366(7):619–28.; Lopes LR, Zekavati A, Syrris P, et al. Genetic complexity in hypertrophic cardiomyopathy revealed by highthroughput sequencing. J Med Genet. 2013;50(4):228–39.; Haas J, Frese KS, Peil B, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J. 2015 May 7;36(18):1123–35.; Gerull B. The Rapidly Evolving Role of Titin in Cardiac Physiology and Cardiomyopathy. Can J Cardiol. 2015;31(11):1351–9.; Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005 Jul 5;46(1):101–5.; Jorholt J, Formicheva Y, Vershinina T, et al. Two new cases of hypertrophic cardiomyopathy and skeletal muscle features associated with alpk3 homozygous and compound heterozygous variants. Genes (Basel). 2020 Oct 1;11(10):1–9.; Marian AJ, Braunwald E. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res. 2017 Sep 1;121(7):749–70.; Chintanaphol M, Orgil BO, Alberson NR, et al. Restrictive cardiomyopathy: from genetics and clinical overview to animal modeling. Rev Cardiovasc Med. 2022 Mar 1;23(3).; Zhang C, Zhang H, Wu G, et al. Titin-Truncating Variants Increase the Risk of Cardiovascular Death in Patients With Hypertrophic Cardiomyopathy. Can J Cardiol. 2017 Oct 1;33(10):1292–7.; https://transmed.almazovcentre.ru/jour/article/view/900

الاتاحة: https://transmed.almazovcentre.ru/jour/article/view/900
https://doi.org/10.18705/2311-4495-2023-10-5-430-448

المؤلفون: S. E. Andreeva, P. P. Snetkov, Yu. A. Vakhrushev, I. A. Piankov, O. O. Yaznevich, M. A. Bortsova, S. N. Morozkina, A. V. Kajava, A. A. Kostareva, M. V. Uspenskaya, С. Е. Андреева, П. П. Снетков, Ю А. Вахрушев, И. А. Пьянков, О. О. Язневич, М. А. Борцова, С. Н. Морозкина, А. В. Каява, А. А. Кoстарева, М. В. Успенская

المساهمون: The work was carried out with the financial support of the Russian Science Foundation (project No. 21-74-20093)., Работа выполнена при финансовой поддержке Российского научного фонда (проект № 21-7420093).

المصدر: Translational Medicine; Том 9, № 6 (2022); 26-35 ; Трансляционная медицина; Том 9, № 6 (2022); 26-35 ; 2410-5155 ; 2311-4495

مصطلحات موضوعية: TTN, bioinformatic analysis, chronic heart failure, molecular modeling, myocardium, proteostasis, titin, биоинформатический анализ, миокард, молекулярное моделирование, протеостаз, тайтин, хроническая сердечная недостаточность

وصف الملف: application/pdf

Relation: https://transmed.almazovcentre.ru/jour/article/view/746/490; https://transmed.almazovcentre.ru/jour/article/downloadSuppFile/746/1598; https://transmed.almazovcentre.ru/jour/article/downloadSuppFile/746/1599; https://transmed.almazovcentre.ru/jour/article/downloadSuppFile/746/1600; https://transmed.almazovcentre.ru/jour/article/downloadSuppFile/746/1601; McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–3726. DOI:10.1093/eurheartj/ehab368.; Lippi G, Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Med J. 2020;5:15. DOI:10.21037/amj.2020.03.03.; Gouveia M, Schmidt C, Teixeira M, et al. Characterization of Plasma SDS-Protein Aggregation Profile of Patients with Heart Failure with Preserved Ejection Fraction. J Cardiovasc Transl Res. 2022. DOI:10.1007/s12265-022-10334-w.; Henning RH, Brundel BJJM. Proteostasis in cardiac health and disease. Nat Rev Cardiol. 2017;14(11):637–653. DOI:10.1038/nrcardio.2017.89.; Ayyadevara S, Mercanti F, Wang X, et al. Age- and Hypertension-Associated Protein Aggregates in Mouse Heart Have Similar Proteomic Profiles. Hypertension. 2016;67(5):1006–1013. DOI:10.1161/HYPERTENSIONAHA.115.06849.; Hahn VS, Yanek LR, Vaishnav J, et al. Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis. JACC Heart Fail. 2020;8(9):712–724. DOI:10.1016/j.jchf.2020.04.007.; Gouveia M, Xia K, Colón W, et al. Protein aggregation, cardiovascular diseases, and exercise training: Where do we stand? Ageing Res Rev. 2017;40:1–10. DOI:10.1016/j.arr.2017.07.005.; Predmore JM, Wang P, Davis F, et al. Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation. 2010;121(8):997–1004. DOI:10.1161/CIRCULATIONAHA.109.904557.; Rubin J, Maurer MS. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable. Annu Rev Med. 2020;71:203–219. DOI:10.1146/annurev-med-052918-020140.; Baker KR, Rice L. The amyloidoses: clinical features, diagnosis and treatment. Methodist Debakey Cardiovasc J. 2012;8(3):3–7. DOI:10.14797/mdcj-8-3-3.; Sawaya MR, Hughes MP, Rodriguez JA, et al. The expanding amyloid family: Structure, stability, function, and pathogenesis. Cell. 2021;184(19):4857–4873. DOI:10.1016/j.cell.2021.08.013.; Kajava AV, Baxa U, Steven AC. Beta arcades: recurring motifs in naturally occurring and disease-related amyloid fibrils. FASEB J. 2010;24(5):1311–1319. DOI:10.1096/fj.09-145979.; Makin OS, Serpell LC. Structures for amyloid fibrils. FEBS J. 2005;272(23):5950–5961. DOI:10.1111/j.1742-4658.2005.05025.x.; Morimoto RI. Cell-Nonautonomous Regulation of Proteostasis in Aging and Disease. Cold Spring Harb Perspect Biol. 2020;12(4):a034074. DOI:10.1101/cshperspect.a034074.; Klaips CL, Jayaraj GG, Hartl FU. Pathways of cellular proteostasis in aging and disease. J Cell Biol. 2018;217(1):51–63. DOI:10.1083/jcb.201709072.; Ihne S, Morbach C, Obici L, et al. Amyloidosis in Heart Failure. Curr Heart Fail Rep. 2019;16(6):285–303. DOI:10.1007/s11897-019-00446-x.; Yamamoto H, Yokochi T. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment. ESC Heart Fail. 2019;6(6):1128–1139. DOI:10.1002/ehf2.12518.; Blancas-Mejia LM, Misra P, Dick CJ, et al. Immunoglobulin light chain amyloid aggregation. Chem Commun (Camb). 2018;54(76):10664–10674. DOI:10.1039/c8cc04396e.; Mann BK, Bhandohal JS, Cobos E, et al. LECT2 amyloidosis: what do we know? J Investig Med. 2022;70(2):348–353. DOI:10.1136/jim-2021-002149.; Arias CQ, Martic S. Gelsolin Amyloidosis: aggregation propensities of wild and mutant peptides and their inhibition. Alzheimer’s Dement. 2021;17(S2):e058332. DOI:10.1002/alz.058332.; Olivé M, Abdul-Hussein S, Oldfors A, et al. New cardiac and skeletal protein aggregate myopathy associated with combined MuRF1 and MuRF3 mutations. Hum Mol Genet. 2015;24(13):3638–3650. DOI:10.1093/hmg/ddv108.; Zaganas I, Mastorodemos V, Spilioti M, et al. Genetic cause of heterogeneous inherited myopathies in a cohort of Greek patients. Mol Genet Metab Rep. 2020;25:100682. DOI:10.1016/j.ymgmr.2020.100682.; Yilmaz A, Bauersachs J, Bengel F, et al. Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK). Clin Res Cardiol. 2021;110(4):479–506. DOI:10.1007/s00392-020-01799-3.; Protein Data Bank. https://www.rcsb.org; Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596(7873):583–589. DOI:10.1038/s41586-02103819-2.; Mirdita M, Schütze K, Moriwaki Y, et al. ColabFold: making protein folding accessible to all. Nat Methods. 2022;19(6):679–682. DOI:10.1038/s41592-02201488-1.; Falgarone T, Villain É, Guettaf A, et al. TAPASS: Tool for annotation of protein amyloidogenicity in the context of other structural states. J Struct Biol. 2022;214(1):107840. DOI:10.1016/j.jsb.2022.107840.; TAPASS — Tool for Annotation of Protein Amyloidogenicity in the context of other Structural States. https://bioinfo.crbm.cnrs.fr/index.php?route=tools&tool=32; Winkler PA, Huang Y, Sun W, et al. Electron cryomicroscopy structure of a human TRPM4 channel. Nature. 2017;552(7684):200–204. DOI:10.1038/nature24674.; Osmanli Z, Falgarone T, Samadova T, et al. The Difference in Structural States between Canonical Proteins and Their Isoforms Established by Proteome-Wide Bioinformatics Analysis. Biomolecules. 2022;12(11):1610. DOI:10.3390/biom12111610.; Schrödinger Technical. The PyMOL Molecular Graphics System. https://pymol.org/2/(2015); Azad A, Poloni G, Sontayananon N, et al. The giant titin: how to evaluate its role in cardiomyopathies. J Muscle Res Cell Motil. 2019;40(2):159–167. DOI:10.1007/s10974019-09518-w.; Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2021;42(16):1554–1568. DOI:10.1093/eurheartj/ehab072.; Yan WF, Gao Y, Zhang Y, et al. Impact of type 2 diabetes mellitus on left ventricular diastolic function in patients with essential hypertension: evaluation by volumetime curve of cardiac magnetic resonance. Cardiovasc Diabetol. 2021;20(1):73. DOI:10.1186/s12933-021-01262-1.; https://transmed.almazovcentre.ru/jour/article/view/746

الاتاحة: https://transmed.almazovcentre.ru/jour/article/view/746
https://doi.org/10.18705/2311-4495-2022-9-6-26-35

المؤلفون: M. A. Simonenko, M. Yu. Sitnikova, P. A. Fedotov, Yu. V. Sazonova, M. A. Bortsova, K. I. Monosova, L. A. Vasilievna, L. B. Mitrofanova, G. V. Nikolaev, M. L. Gordeev, M. A. Karpenko, М. А. Симоненко, М. Ю. Ситникова, П. А. Федотов, Ю. В. Сазонова, М. А. Борцова, К. И. Моносова, Л. А. Васильева, Л. Б. Митрофанова, Г. В. Николаев, М. Л. Гордеев, М. А. Карпенко

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 23, № 2 (2021); 30-35 ; Вестник трансплантологии и искусственных органов; Том 23, № 2 (2021); 30-35 ; 2412-6160 ; 1995-1191

مصطلحات موضوعية: инвазивный аспергиллез легких, infectious complications, invasive pulmonary aspergillosis, инфекционные осложнения

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/1299/1102; https://journal.transpl.ru/vtio/article/view/1299/1202; https://journal.transpl.ru/vtio/article/downloadSuppFile/1299/744; https://journal.transpl.ru/vtio/article/downloadSuppFile/1299/745; https://journal.transpl.ru/vtio/article/downloadSuppFile/1299/746; https://journal.transpl.ru/vtio/article/downloadSuppFile/1299/747; https://journal.transpl.ru/vtio/article/downloadSuppFile/1299/748; https://journal.transpl.ru/vtio/article/downloadSuppFile/1299/749; https://journal.transpl.ru/vtio/article/downloadSuppFile/1299/750; https://journal.transpl.ru/vtio/article/downloadSuppFile/1299/751; ISHLT Registry – Heart Transplantation: overall. JHLT. 2019 Oct; 38 (10): 1015–1066.; Федотов ПА, Сазонова ЮВ, Рубинчик ВЕ, Симоненко МА, Ситникова МЮ. Инфекционные осложнения в краткосрочной и отдаленной перспективе у пациентов с трансплантированным сердцем. Трансплантология. 2015; 3: 47–53.; Hummel M. Early postoperative therapy after heart transplantation: prophylaxis, diagnosis and antibiotic, antimycotic and antiviral therapy of infections. Transplantationsmedizin. 2011; 23: 190–197.; Montoya JG, Chaparro SV, Celis D, Cortes JA, Leung AN, Robbins RC, Stevens DA. Invasive aspergillosis in the setting of cardiac transplantation. Clinical Infectious Diseases. 2003; 37 (Suppl. 3): S281–292.; Munoz P, Rodriguez C, Bouza E, Palomo J, Yanez JF, Dominguez MJ, Desco M. Risk factors of invasive aspergillosis after heart transplantation: protective role of oral Itraconazole prophylaxis. American Journal of Transplantation. 2004; 4: 636–643. doi:10.1111/j.1600-6143.2004.00390.x.; Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S et al. Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management, ESCMID/ERS Guidelines: Task force report. Eur Respir J. 2016; 47: 45–68. doi:10.1183/13993003.00583-2015.; Al-Abdely HM, Alothman AF, Al Salman J, Al-Musawi T, Almaslamani M, Butt AA et al. Clinical practice guidelines for the treatment of invasive Aspergillus infections in adults in the Middle East region: Expert panel recommendations. Journal of Infection and Public Health by Elsevier. 2014; 7: 20–31. doi:10.1016/j.jiph.2013.08.003.; Симоненко МА, Николаев ГВ, Маликов КН, Федотов ПА, Сазонова ЮВ, Борцова МА и др. Трансплантация сердца у реципиентов с исходной легочной гипертензией: 9-летний опыт НМИЦ им. В.А. Алмазова. Вестник трансплантологии и искусственных органов. 2019; 21 (4): 7–13. doi:10.15825/1995-1191-2019-4-7-13.; Misch EA, Safdar N. Updated guidelines for the diagnosis and management aspergillosis. Journal of Thoracic Disease. 2016; 8 (12): E1771–E1776.; Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K. Dignosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical Microbiology and Infection. 2018; 24: e1–e38. doi:10.1016/j.cmi.2018.01.002.; Singh N, Paterson DL. Aspergillus Infections in Transplant Recipients. Clinical Microbiology Reviews. 2005; 18 (1): 44–49. doi:10.1128/CMR.18.1.44-69-2005.; Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis. 2001; 33: 629–640.; Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA et al. Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2008; 46: 327–360. doi:10.1086/525258.; Pelaez T, Munoz P, Guinea J, Valerio M, Giannella M, Klaassen CHW, Bouza E. Outbreak of Invasive Aspergillosis after major heart surgery caused by spores in the air of the intensive care unit. Clin Infect Dis. 2012; 54 (3): e24–e31. doi:10.1093/cid/cir771.; Patterson TF, Thompson GR III, Denning DW, Fishman JA, Hadley S, Herbrecht R et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases. 2016; 63 (4): e1–60. doi:10.1093/cid/ciw326.; https://journal.transpl.ru/vtio/article/view/1299

الاتاحة: https://journal.transpl.ru/vtio/article/view/1299
https://doi.org/10.15825/1995-1191-2021-2-30-35

المؤلفون: M. A. Simonenko, G. V. Nikolayev, K. N. Malikov, P. A. Fedotov, Y. V. Sazonova, M. A. Bortsova, V. E. Rubinchik, A. O. Marichev, A. E. Bautin, M. Y. Sitnikova, M. L. Gordeev, M. A. Karpenko, М. А. Симоненко, Г. В. Николаев, К. Н. Маликов, П. А. Федотов, Ю. В. Сазонова, М. А. Борцова, В. Е. Рубинчик, А. О. Маричев, А. Е. Баутин, М. Ю. Ситникова, М. Л. Гордеев, М. А. Карпенко

المصدر: Russian Journal of Transplantology and Artificial Organs; Том 21, № 4 (2019); 7-13 ; Вестник трансплантологии и искусственных органов; Том 21, № 4 (2019); 7-13 ; 2412-6160 ; 1995-1191 ; 10.15825/1995-1191-2019-4

مصطلحات موضوعية: вазодилататоры, heart failure, pulmonary hypertension, PH, pulmonary artery pressure, PAP, pulmonary vascular resistance, PVR, vasodilators, сердечная недостаточность, легочная гипертензия, давление в легочной артерии, легочное сосудистое сопротивление

وصف الملف: application/pdf

Relation: https://journal.transpl.ru/vtio/article/view/1101/858; https://journal.transpl.ru/vtio/article/view/1101/880; Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al. 2015 ESC/ERC Guidelines for the diagnosis and treatment of pulmonary hypertension, European Society of Cardiology / European Respiratory Society. Eur Heart J. 2016; 37: 67–119. doi:10.1093/eurheartj/ehv317.; Roldan C. The ultimate echo guide. Lippincott Williams and Wilkins, 2005. PMCID: PMC2650657.; Delgado JF, Gomez-Sanchez MA, Saenz de la Calzada C, Sanchez V, Escribano SV, Hernandez-Afonso et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. Journal of Heart Lung Transplantation. 2001; 20: 942–948. PMID: 11557188. doi:10.1016/s10532498(01)00286-8.; Deng MC, Gradaus R, Hammel D, Weyand M., Gunther F, Kerber S et al. Heart Transplant candidates at high risk can be identified at the time of initial evaluation. Transplantat International. 1996; 9 (1): 38–45. PMID: 8748409. doi:10.1007/bf00336810.; Ross H, Hendry P, Dipchand A, Giannetti N, Hirsch G, Isaac D et al. Canadian Cardiovascular Society Consensus Conference on cardiac transplantation. Canadian Journal of Cardiology. 2003; 19: 620–654. PMCID: PMC2706756.; Kettner A, Dorazilova Z, Netuka I, Maly J, Al-hiti H, Melenovsky V et al. Is severe pulmonary hypertension a contraindication for orthotopic heart transplantation? Not any more. Physiol Res. 2011; 60 (5): 769–775. PMID: 21812520.; Klotz S, Wenzelburger F, Stypmann J, Welp H, Drees G, Schmid C et al. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant. The annals of thoracic surgery. 2006; 82 (5): 1770–1773. doi:10.1016/j.athoracsur.2006.05.114.; Hill NS, Roberts KR, Preston IR. Postoperative Pulmonary Hypertension: Etiology and Treatment of a Dangerous Complication. Respiratory Care. 2009; 54 (7): 958–968. PMID: 19558745.; Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe lowoutput heart failure (the LIDO study): a randomized double-blind trial. Lancet. 2002; 360 (9328): 196–202. PMID: 12133653.; Mogollon Jimenez MV, Escoresca Prtega AM, Cabeza Letran ML, Hinojosa Perez R, Galle EL, Sobrino Marquez JM et al. Correlation of Echocardiographic and Hemodynamic Parameters in Pulmonary Hypertension Assessment Prior to Heart Transplantation. Transplantation Proceedings. 2008; 40: 3023–3024. doi:10.1016/j.transproceed.2008.09.044.; Zeng Z, Jiang Z, Wang CS, Luo H, Huang YF, Jin XH. Preoperative Evaluation Improves the Outcome in Heart Transplant Recipients With Pulmonary Hypertension Retrospective Analysis of 106 Cases. Transplantation Proceedings by ELSEVIER. 2010; 42: 3708–3710. doi:10.1016/j.transproceed.2010.08.067.; Klotz S, Deng MC, Hanafy D, Schmid C, Stypmann J, Schmidt C et al. Reversible pulmonary hypertension in heart transplant candidates – pretransplant evalution and outcome after orthotopic heart transplantation. The European Journal of Heart Failure. 2003; 5: 645–653. doi:10.1016/S1388-9842(03)00059-X.; Drakos SG, Kfoure AG, Gilbert EM, Horne BD, Long JW, Strangham JC et al. Effect of reversible pulmonary hypertension on outcomes after heart transplantation. The Journal of Heart and Lung Transplantation. 2007; 26 (4): 319–323. doi:10.1016/j.healun.2007.01.012.; Gude E, Simonsen S, Geiran OR, Fiane AE, Gullestad L, Arora S et al. Pulmonary hypertension in heart transplantation: Discrepant prognostic impact of pre-operative compared with 1-year post-operative right heart hemodynamics. The Journal of Heart and Lung Transplantation. 2010; 29 (2): 216–223. doi:10.1016/j.healun.2009.08.021.; Lindelow B, Andersson B, Waagstein F, Bergh CH. High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. European Heart Journal. 1999; 20: 148–156. PMID: 10099912.; Kitamura S, Nakatani T, Kato T, Yanase M, Kobayashi J, Nakajima H et al. Hemodynamic and Echocardiographic Evaluation of Orthotopic Heart Transplantation with the modified bicaval anastomosis technique. Circulation Journal. 2009; 73 (7): 1235–1239. PMID: 19398842. doi:10.1253/circj.cj-08-1098.; Баутин АЕ, Яковлев АС, Заяшников СВ, Ташханов ДМ, Маричев АО, Федотов ПА и др. Сравнение гемодинамических эффектов ингаляционного илопроста и оксида азота при назначении пациентам с выраженной систолической дисфункцией левого желудочка. Российский кардиологический журнал. 2017; 12 (152): 97–103. doi:10.15829/1560-4071-201712-97-103.; Борцова МА, Баутин АЕ, Яковлев АС, Федотов ПА, Сазонова ЮВ, Маричев АО и др. О возможности повышения информативности диагностики необратимой легочной гипертензии у кандидатов на трансплантацию сердца. Альманах клинической медицины. 2019; 47 (3): 212–220. doi:10.18786/2072-0505-201947-030.; Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasckaran K et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A report from the American society of echocardiography. Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. Journal American Society of Echocardiology. 2010; 23: 685–713. PMID: 20620859. doi: 110.1016/j.echo.2010.05.010.; Wong RC, Abrahams Z, Hanna M, Pangrace J, Gonzalez-Stawinski G, Starling R et al. Tricuspid Regurgitation after Cardiac Transplantation: An Old Problem Revisited. Journal of Heart and Lung Transplantation. 2008; 27 (3): 247–252. doi:10.1016/j.healun.2007.12.011.; Barst RJ, Galle N, Naelje R, Simonneau G, Jeffs R, Arneson C et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. European Respiratory Journal. 2006; 28: 11951203. doi:10.1183/09031936.06.00044406.; Шемакин СЮ, Халилулин ТА, Федосеева АА. Недостаточность трикуспидального клапана после ортотопической трансплантации сердца. Вестник трансплантологии и искусственных органов. 2009; 11 (2): 21–24.; Mogollon MV, Galle EL, Perez RH, Aviles AH, Sobrino Marquez JM, Rodriguez NR et al. Prognosis after Heart Transplant in Patients with Pulmonary Hypertension Secondary to Cardiopathy. Transplantation Proceedings. 2008; 40: 3031–3033. doi:10.1016/j.transproceed.2008.09.051.; Ghio S, Crimi G, Pica S, Temporelli PL, Boffini M, Rinaldi M et al. Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension. Plos One. 2017; 13 (12): 1–10. doi:10.1371/journal.pone.0188383.; Al-Hiti H, Melenovsky V, Syrovatka P, Kettner J, Malek I, Kautzner J. Sildenafil is more selective pulmonary vasodilator than Prostaglandin E1 in Patients with Pulmonary Hypertension Due to Heart Failure. Physiol Res. 2011; 60: 303–308. ISSN 1802-9973.; Seferian A, Simonneau G. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? European Respiratory Revision. 2013; 22: 217–226. doi:10.1183/09059180.00001713.; https://journal.transpl.ru/vtio/article/view/1101

الاتاحة: https://journal.transpl.ru/vtio/article/view/1101
https://doi.org/10.15825/1995-1191-2019-4-7-13